image
Healthcare - Medical - Devices - NASDAQ - CR
$ 37.79
0.747 %
$ 1.09 B
Market Cap
-14.48
P/E
1. INTRINSIC VALUE

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.[ Read More ]

The intrinsic value of one ESTA stock under the base case scenario is HIDDEN Compared to the current market price of 37.8 USD, Establishment Labs Holdings Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ESTA

image
FINANCIALS
165 M REVENUE
2.13%
-65 M OPERATING INCOME
-63.97%
-78.5 M NET INCOME
-4.38%
-88.5 M OPERATING CASH FLOW
-69.68%
-24.5 M INVESTING CASH FLOW
29.44%
86.2 M FINANCING CASH FLOW
-13.99%
40.2 M REVENUE
-8.82%
-13.1 M OPERATING INCOME
-40.61%
-16.7 M NET INCOME
2.90%
-12.4 M OPERATING CASH FLOW
12.35%
-2.76 M INVESTING CASH FLOW
37.35%
-28 K FINANCING CASH FLOW
-7.20%
Balance Sheet Decomposition Establishment Labs Holdings Inc.
image
Current Assets 175 M
Cash & Short-Term Investments 40 M
Receivables 46.9 M
Other Current Assets 87.9 M
Non-Current Assets 93.7 M
Long-Term Investments 0
PP&E 80.6 M
Other Non-Current Assets 13.2 M
Current Liabilities 57.2 M
Accounts Payable 41.6 M
Short-Term Debt 773 K
Other Current Liabilities 14.8 M
Non-Current Liabilities 193 M
Long-Term Debt 191 M
Other Non-Current Liabilities 1.64 M
EFFICIENCY
Earnings Waterfall Establishment Labs Holdings Inc.
image
Revenue 165 M
Cost Of Revenue 58.2 M
Gross Profit 107 M
Operating Expenses 172 M
Operating Income -65 M
Other Expenses 13.5 M
Net Income -78.5 M
RATIOS
64.78% GROSS MARGIN
64.78%
-39.37% OPERATING MARGIN
-39.37%
-47.53% NET MARGIN
-47.53%
-426.76% ROE
-426.76%
-29.22% ROA
-29.22%
-31.36% ROIC
-31.36%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Establishment Labs Holdings Inc.
image
Net Income -78.5 M
Depreciation & Amortization 4.88 M
Capital Expenditures -24.5 M
Stock-Based Compensation 14.4 M
Change in Working Capital -34.1 M
Others 9.28 M
Free Cash Flow -112 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Establishment Labs Holdings Inc.
image
Wall Street analysts predict an average 1-year price target for ESTA of $60 , with forecasts ranging from a low of $45 to a high of $70 .
ESTA Lowest Price Target Wall Street Target
45 USD 19.08%
ESTA Average Price Target Wall Street Target
60 USD 58.77%
ESTA Highest Price Target Wall Street Target
70 USD 85.23%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Establishment Labs Holdings Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
677 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
214 K USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
4 months ago
Jul 11, 2024
Sell 164 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 3641
45.0396 USD
4 months ago
Jul 08, 2024
Sell 174 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 3866
45.0108 USD
4 months ago
Jul 09, 2024
Sell 29.4 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 654
45.0008 USD
4 months ago
Jul 01, 2024
Sell 310 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 6839
45.2954 USD
11 months ago
Dec 14, 2023
Bought 47.8 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 1769
27.047 USD
11 months ago
Dec 14, 2023
Bought 6.23 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 231
26.955 USD
11 months ago
Nov 20, 2023
Bought 110 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 5000
22 USD
1 year ago
Nov 17, 2023
Bought 50 K USD
Denhoy Raj
Chief Financial Officer
+ 2250
22.21 USD
1 year ago
Aug 15, 2023
Bought 22.5 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 400
56.13 USD
1 year ago
Mar 15, 2023
Sell 254 K USD
Gillin Leslie
Director
- 3759
67.62 USD
2 years ago
May 13, 2022
Bought 274 K USD
Wild Jason G.
director:
+ 5000
54.83 USD
2 years ago
May 13, 2022
Bought 274 K USD
JW Asset Management, LLC
10 percent owner
+ 5000
54.83 USD
2 years ago
May 09, 2022
Bought 575 K USD
Wild Jason G.
director:
+ 10000
57.52 USD
2 years ago
May 09, 2022
Bought 575 K USD
JW Asset Management, LLC
10 percent owner
+ 10000
57.52 USD
3 years ago
Mar 17, 2021
Bought 21 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 350
59.97 USD
5 years ago
May 23, 2019
Bought 986 USD
LEWIN NICHOLAS SHERIDAN
Director
+ 45
21.91 USD
5 years ago
May 17, 2019
Bought 3 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 112
26.79 USD
2 years ago
Apr 13, 2022
Bought 2.45 M USD
Wild Jason G.
director:
+ 35000
70.01 USD
2 years ago
Apr 13, 2022
Bought 2.45 M USD
JW Asset Management, LLC
10 percent owner
+ 35000
70.01 USD
2 years ago
Mar 14, 2022
Bought 526 K USD
JW Asset Management, LLC
10 percent owner
+ 10000
52.63 USD
2 years ago
Mar 14, 2022
Bought 526 K USD
Wild Jason G.
director:
+ 10000
52.63 USD
2 years ago
Mar 02, 2022
Bought 297 K USD
Wild Jason G.
director:
+ 5000
59.45 USD
2 years ago
Mar 02, 2022
Bought 297 K USD
JW Asset Management, LLC
10 percent owner
+ 5000
59.45 USD
2 years ago
Feb 28, 2022
Bought 594 K USD
JW Asset Management, LLC
10 percent owner
+ 10000
59.42 USD
2 years ago
Nov 24, 2021
Bought 2.01 M USD
SCHUTTER EDWARD J
Director
+ 30000
67 USD
2 years ago
Nov 23, 2021
Bought 154 K USD
SCHUTTER EDWARD J
Director
+ 2467
62.5 USD
3 years ago
Nov 18, 2021
Bought 7.19 K USD
SCHUTTER EDWARD J
Director
+ 100
71.87 USD
3 years ago
Nov 18, 2021
Bought 7.18 K USD
SCHUTTER EDWARD J
Director
+ 100
71.84 USD
3 years ago
Nov 18, 2021
Bought 2.15 M USD
SCHUTTER EDWARD J
Director
+ 29800
72 USD
3 years ago
Nov 17, 2021
Bought 177 K USD
SCHUTTER EDWARD J
Director
+ 2560
69 USD
3 years ago
Sep 10, 2021
Sell 3.6 K USD
CONDON DENNIS E
Director
- 50
71.919 USD
3 years ago
Sep 10, 2021
Sell 281 K USD
CONDON DENNIS E
Director
- 3872
72.6585 USD
3 years ago
Sep 10, 2021
Sell 135 K USD
CONDON DENNIS E
Director
- 1843
73.4724 USD
3 years ago
Sep 10, 2021
Sell 194 K USD
CONDON DENNIS E
Director
- 2611
74.3705 USD
3 years ago
Sep 10, 2021
Sell 40.1 K USD
CONDON DENNIS E
Director
- 534
75.1304 USD
3 years ago
Sep 10, 2021
Sell 6.84 K USD
CONDON DENNIS E
Director
- 90
76 USD
3 years ago
Aug 05, 2021
Sell 896 K USD
Gersh Lisa
Director
- 12758
70.2657 USD
3 years ago
Aug 05, 2021
Sell 374 K USD
Gersh Lisa
Director
- 5242
71.2707 USD
3 years ago
Jun 09, 2021
Sell 154 K USD
CONDON DENNIS E
Director
- 1988
77.6336 USD
3 years ago
Jun 09, 2021
Sell 96.8 K USD
CONDON DENNIS E
Director
- 1229
78.7283 USD
3 years ago
Jun 09, 2021
Sell 459 K USD
CONDON DENNIS E
Director
- 5772
79.5495 USD
3 years ago
Jun 09, 2021
Sell 880 USD
CONDON DENNIS E
Director
- 11
80 USD
3 years ago
May 21, 2021
Sell 99.8 K USD
De Mezerville Roberto
Chief Technology Officer
- 1336
74.7335 USD
3 years ago
May 21, 2021
Sell 190 K USD
De Mezerville Roberto
Chief Technology Officer
- 2524
75.4335 USD
3 years ago
May 21, 2021
Sell 15.7 K USD
De Mezerville Roberto
Chief Technology Officer
- 206
76.0096 USD
3 years ago
May 21, 2021
Sell 51.9 K USD
Gaeta Renee
Chief Financial Officer
- 694
74.7272 USD
3 years ago
May 21, 2021
Sell 148 K USD
Gaeta Renee
Chief Financial Officer
- 1958
75.3473 USD
3 years ago
May 21, 2021
Sell 14.3 K USD
Gaeta Renee
Chief Financial Officer
- 188
76.0652 USD
3 years ago
May 20, 2021
Sell 466 K USD
Gaeta Renee
Chief Financial Officer
- 6260
74.3722 USD
3 years ago
May 21, 2021
Sell 84.9 K USD
De Mezerville Roberto
Chief Technology Officer
- 1136
74.7335 USD
3 years ago
May 21, 2021
Sell 190 K USD
De Mezerville Roberto
Chief Technology Officer
- 2524
75.4335 USD
3 years ago
May 21, 2021
Sell 15.7 K USD
De Mezerville Roberto
Chief Technology Officer
- 206
76.0096 USD
3 years ago
May 18, 2021
Sell 3.26 K USD
De Mezerville Roberto
Chief Technology Officer
- 44
74 USD
3 years ago
May 19, 2021
Sell 104 K USD
De Mezerville Roberto
Chief Technology Officer
- 1400
74.3232 USD
3 years ago
May 20, 2021
Sell 706 K USD
De Mezerville Roberto
Chief Technology Officer
- 9490
74.4018 USD
3 years ago
May 19, 2021
Sell 59.4 K USD
Gaeta Renee
Chief Financial Officer
- 800
74.3056 USD
3 years ago
May 18, 2021
Sell 7.4 K USD
Gaeta Renee
Chief Financial Officer
- 100
74 USD
3 years ago
Mar 17, 2021
Bought 21 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 350
59.97 USD
3 years ago
Jan 12, 2021
Sell 467 K USD
Dada Santos Salvador
Chief Operating Officer
- 9253
50.4863 USD
3 years ago
Jan 12, 2021
Sell 25.5 K USD
Dada Santos Salvador
Chief Operating Officer
- 500
51.015 USD
3 years ago
Jan 13, 2021
Sell 501 K USD
Dada Santos Salvador
Chief Operating Officer
- 9947
50.3584 USD
3 years ago
Jan 13, 2021
Sell 15.3 K USD
Dada Santos Salvador
Chief Operating Officer
- 300
51.0258 USD
3 years ago
Jan 11, 2021
Sell 781 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 19392
40.2999 USD
3 years ago
Jan 11, 2021
Sell 18.5 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 451
41 USD
3 years ago
Jan 12, 2021
Sell 29 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 700
41.4914 USD
3 years ago
Jan 12, 2021
Sell 63.7 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 1500
42.4863 USD
3 years ago
Jan 12, 2021
Sell 69.3 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 1600
43.3173 USD
3 years ago
Jan 12, 2021
Sell 309 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 6900
44.7106 USD
3 years ago
Jan 12, 2021
Sell 294 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 6500
45.1645 USD
3 years ago
Jan 12, 2021
Sell 261 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 5575
46.8187 USD
3 years ago
Jan 12, 2021
Sell 339 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 7182
47.233 USD
3 years ago
Jan 12, 2021
Sell 9.62 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 200
48.125 USD
5 years ago
Aug 19, 2019
Bought 54.3 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 2700
20.1069 USD
3 years ago
Jan 06, 2021
Sell 293 K USD
De Mezerville Roberto
Chief Technology Officer
- 7700
38.1138 USD
3 years ago
Jan 07, 2021
Sell 87.5 K USD
De Mezerville Roberto
Chief Technology Officer
- 2300
38.0437 USD
3 years ago
Dec 30, 2020
Sell 14.7 K USD
Dada Santos Salvador
Chief Operating Officer
- 421
35.0309 USD
3 years ago
Dec 24, 2020
Sell 70.1 K USD
Dada Santos Salvador
Chief Operating Officer
- 2000
35.0542 USD
3 years ago
Dec 28, 2020
Sell 119 K USD
Dada Santos Salvador
Chief Operating Officer
- 3400
35.0036 USD
3 years ago
Dec 29, 2020
Sell 199 K USD
Dada Santos Salvador
Chief Operating Officer
- 5679
35.0238 USD
3 years ago
Dec 22, 2020
Sell 17.5 K USD
Dada Santos Salvador
Chief Operating Officer
- 500
35.0724 USD
3 years ago
Dec 23, 2020
Sell 105 K USD
Dada Santos Salvador
Chief Operating Officer
- 3000
35.0062 USD
3 years ago
Dec 15, 2020
Sell 66 K USD
De Mezerville Roberto
Chief Technology Officer
- 2000
33.0018 USD
3 years ago
Dec 17, 2020
Sell 265 K USD
De Mezerville Roberto
Chief Technology Officer
- 8000
33.1439 USD
3 years ago
Dec 07, 2020
Sell 301 K USD
De Mezerville Roberto
Chief Technology Officer
- 10000
30.1427 USD
3 years ago
Dec 01, 2020
Sell 8.11 K USD
Dada Santos Salvador
Chief Operating Officer
- 300
27.0233 USD
3 years ago
Dec 02, 2020
Sell 214 K USD
Dada Santos Salvador
Chief Operating Officer
- 7786
27.4866 USD
3 years ago
Dec 03, 2020
Sell 134 K USD
Dada Santos Salvador
Chief Operating Officer
- 4915
27.2838 USD
3 years ago
Nov 27, 2020
Sell 8.1 K USD
Dada Santos Salvador
Chief Operating Officer
- 300
27 USD
3 years ago
Nov 24, 2020
Sell 224 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 8367
26.735 USD
3 years ago
Nov 25, 2020
Sell 19.2 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 729
26.3399 USD
3 years ago
Nov 20, 2020
Sell 5.41 K USD
Dada Santos Salvador
Chief Operating Officer
- 200
27.035 USD
3 years ago
Nov 24, 2020
Sell 24.3 K USD
Dada Santos Salvador
Chief Operating Officer
- 899
27.05 USD
3 years ago
Nov 19, 2020
Sell 38 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 1447
26.2718 USD
3 years ago
Nov 20, 2020
Sell 279 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 10491
26.549 USD
3 years ago
Nov 23, 2020
Sell 121 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 4577
26.3815 USD
4 years ago
Nov 16, 2020
Sell 39.4 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 1500
26.2767 USD
4 years ago
Nov 17, 2020
Sell 352 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 13328
26.422 USD
4 years ago
Nov 18, 2020
Sell 81.5 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 3102
26.2799 USD
4 years ago
Nov 11, 2020
Sell 172 K USD
Chacon Quiros Juan Jose
Chief Executive Officer
- 6459
26.5839 USD
4 years ago
Nov 11, 2020
Sell 16.3 K USD
Dada Santos Salvador
Chief Operating Officer
- 600
27.1237 USD
4 years ago
May 22, 2020
Bought 20.8 K USD
COLLERAN LISA N
Director
+ 1165
17.8325 USD
4 years ago
May 13, 2020
Bought 171 USD
De Mezerville Roberto
Chief Technology Officer
+ 10
17.13 USD
5 years ago
Sep 04, 2019
Bought 10.2 K USD
COLLERAN LISA N
Director
+ 535
19.13 USD
5 years ago
May 23, 2019
Bought 50.2 K USD
COLLERAN LISA N
Director
+ 2300
21.81 USD
5 years ago
Oct 08, 2019
Bought 18.7 K USD
JW Asset Management, LLC
10 percent owner
+ 1000
18.74 USD
5 years ago
Sep 19, 2019
Bought 20 K USD
JW Asset Management, LLC
10 percent owner
+ 1000
20 USD
5 years ago
Aug 23, 2019
Bought 20.4 K USD
JW Asset Management, LLC
10 percent owner
+ 1000
20.4 USD
5 years ago
Aug 20, 2019
Bought 20 K USD
JW Asset Management, LLC
10 percent owner
+ 1000
20 USD
5 years ago
Aug 16, 2019
Bought 42.8 K USD
JW Asset Management, LLC
10 percent owner
+ 2000
21.42 USD
5 years ago
Aug 19, 2019
Bought 54.3 K USD
LEWIN NICHOLAS SHERIDAN
Director
+ 2700
20.1069 USD
5 years ago
Aug 12, 2019
Bought 66.4 K USD
JW Asset Management, LLC
10 percent owner
+ 3000
22.15 USD
5 years ago
Jul 31, 2019
Bought 38 K USD
JW Asset Management, LLC
10 percent owner
+ 1500
25.305 USD
5 years ago
Jul 29, 2019
Bought 63.9 K USD
JW Asset Management, LLC
10 percent owner
+ 2500
25.58 USD
7. News
Establishment Labs Holdings Inc. (ESTA) Q3 2024 Earnings Call Transcript Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q3 2024 Earnings Call Transcript November 7, 2024 4:30 PM ET Company Participants Rajbir Denhoy - Chief Financial Officer Juan Jose - CEO and Founder Conference Call Participants Allen Gong - JPMorgan Matt Taylor - Jefferies Sam Eiber - BTIG Anthony Pettinari - Citi Josh Jennings - TD Cowen Anthony Petrone - Mizuho Group Operator Good afternoon. Welcome to Establishment Labs Third Quarter 2024 Earnings Conference Call. seekingalpha.com - 1 week ago
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Misses Revenue Estimates Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $1.12 per share a year ago. zacks.com - 1 week ago
Establishment Labs Announces $50 Million Registered Direct Offering NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with select purchasers for the purchase of 765,696 common shares and pre-funded warrants to purchase up to 328,161 common shares in a registered direct offering for a. businesswire.com - 1 week ago
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of three-year clinical results with Mia Femtech™ at the 9th Annual World Symposium on Ergonomic Implants (WSEI) being held this week in Barcelona, Spain. The Mia Femtech Clinical Study is an IRB-approved prospective study that enrolled 100 subjects betwee. businesswire.com - 2 weeks ago
Establishment Labs Holdings Inc (ESTA) Stock Price Up 9.25% on Oct 2 Shares of Establishment Labs Holdings Inc (ESTA, Financial) surged 9.25% in mid-day trading on Oct 2. The stock reached an intraday high of $44.42, before settling at $44.31, up from its previous close of $40.56. gurufocus.com - 1 month ago
Establishment Labs Receives U.S. FDA Approval for Motiva Implants NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of Motiva® SmoothSilk® Ergonomix® and Motiva® SmoothSilk® Round breast implants in primary and revision breast augmentation. “Today's approval is transformative for breast aesthetics in. businesswire.com - 1 month ago
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.62 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.65 per share a year ago. zacks.com - 3 months ago
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6 NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2024, after the market closes on Tuesday, August 6, 2024, and will host a conference call at 4:30 pm ET that day to discuss those results. To participate in the conference call, dial (800) 715-9871 (U.S. and Can. businesswire.com - 3 months ago
Establishment Labs (ESTA) Surges 7.4%: Is This an Indication of Further Gains? Establishment Labs (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com - 4 months ago
Establishment Labs Announces Participation in Two Upcoming Investment Conferences NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in two upcoming investment conferences. Juan José Chacón-Quirós, Chief Executive Officer and Founder, and Raj Denhoy, Chief Financial Officer, will participate in the 2024 Jefferies Global Healthcare Conference being held June 5-6, 2024. Mr. Chacón. businesswire.com - 5 months ago
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.48 per share a year ago. zacks.com - 6 months ago
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024 NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, noted the presentation today of an update on the Motiva US IDE Study. The update will include four-year patient follow-up data for primary augmentation subjects. The Medical Director of the Study, Dr. Caroline Glicksman, who is also an Investigator in the Study, will present the re. businesswire.com - 6 months ago
8. Profile Summary

Establishment Labs Holdings Inc. ESTA

image
COUNTRY CR
INDUSTRY Medical - Devices
MARKET CAP $ 1.09 B
Dividend Yield 0.00%
Description Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Contact Building B15 and 25, Alajuela, https://www.establishmentlabs.com
IPO Date July 19, 2018
Employees 908
Officers Mr. Juan Jose Chacon Quiros Founder, Chief Executive Officer & Executive Director Mr. Ivan Bilic Senior Vice President of Commercial Operations - OUS Ms. Neeta Toprani Corporate Secretary Mr. Jeff Ehrhard Senior Vice President & GM of North America Mr. S. Ross Mansbach General Counsel, Chief Compliance Officer & Chief Human Resources Officer Mr. Filippo Caldini President Mr. Roberto de Mezerville Chief Technology Officer Mr. Rajbir Singh Denhoy Chief Financial Officer Mr. Salvador Santos Dada Head of Special Projects Ms. Rosalyn Cole d'Incelli SVice President of Global Clinical, Medical & US Regulatory Affairs